Highlights • A RUNX1/RUNX1T1-associated gene expression network drives acute myeloid leukemia.• RUNX1/RUNX1T1 dysregulates gene expression at multiple levels.• Interrogation of the RUNX1/RUNX1T1 network by RNA interference or CRISPR screens identifies… Click to show full abstract
Highlights • A RUNX1/RUNX1T1-associated gene expression network drives acute myeloid leukemia.• RUNX1/RUNX1T1 dysregulates gene expression at multiple levels.• Interrogation of the RUNX1/RUNX1T1 network by RNA interference or CRISPR screens identifies novel therapeutic targets.• RUNX1/RUNX1T1 drives cell cycle progression in G1 by promoting CCND2 and CDK6 expression.• RUNX11/RUNX1T1-positive AMLs are sensitive toward CDK4/6 inhibitors.
               
Click one of the above tabs to view related content.